On Monday, Morgan Stanley (NYSE:MS) revised its price target for MKS Instruments (NASDAQ:MKSI), a global provider of instruments, systems, and process control solutions, dropping it to $150 from the previous target of $155. The firm maintains its Overweight rating on the stock. According to InvestingPro data, analyst targets for MKSI range from $119 to $160, with 8 analysts recently revising their earnings expectations upward for the upcoming period.
The adjustment comes in the wake of anticipated headwinds in the semiconductor industry. The analyst from Morgan Stanley pointed to a recent report from December 5, 2024, outlining the challenges in the semiconductor production equipment sector for the year 2025, which is expected to be a transition year.
MKS Instruments' exposure to NAND memory production is believed to be a key factor that will drive the company's performance, despite the forecasted stagnation in semiconductor growth in 2025 and modest growth in 2026. The company's semiconductor growth is projected to be 0% in 2025 and 15% in 2026, compared to a wider industry expectation of a 6% decline and 6% increase, respectively, in wafer fabrication equipment (WFE) spending.
Financial estimates for MKS Instruments have been revised, with 2025 revenue projections decreased from approximately $3.976 billion to $3.75 billion, though the gross margin is expected to remain steady at 47.3%. Earnings per share (EPS) estimates for 2025 have also been reduced from $7.76 to $7.20.
Looking ahead to 2026, revenue is forecasted to reach $4.15 billion with a slight increase in gross margin to 47.4% and EPS growing to $8.80, as the company is anticipated to benefit from deleveraging.
InvestingPro analysis shows the company maintains strong liquidity with a current ratio of 3.42, while generating $432 million in levered free cash flow over the last twelve months. Get access to over 30 key financial metrics and additional insights with InvestingPro's comprehensive research report.
The valuation multiple for MKS Instruments has been lowered from 20 times to 17 times earnings, which reflects a slight discount compared to the 18-21 times range typically assigned to semiconductor production equipment (SPE) original equipment manufacturers (OEMs). This adjustment is consistent with the discount MKS Instruments has seen since its acquisition of Atotech in 2021. The analyst does not foresee a near-term contraction in the company's valuation discount, attributing this to its leverage.
Despite these adjustments, MKS Instruments has demonstrated resilience over the past three months, outperforming its SPE OEM peers with a 1% increase in stock price compared to a decline of 1-13% among other OEMs.
This performance is credited to a strong earnings beat in the September quarter. The company is expected to continue this trend, bolstered by its unique growth drivers in NAND and advanced packaging, as well as its potential for outsized EPS growth due to deleveraging.
With a market capitalization of $7.57 billion and a year-to-date return of 10.2%, MKSI has maintained dividend payments for 14 consecutive years, demonstrating consistent shareholder returns. InvestingPro subscribers can access detailed analysis of MKSI's financial health, growth prospects, and valuation metrics through our comprehensive Pro Research Report, available exclusively on the platform.
In other recent news, MKS Instruments has been experiencing steady growth and strategic focus, as indicated by its third-quarter earnings. MKS Instruments reported a 1% sequential increase in Q3 revenue, totaling $896 million, and an operating income of $195 million. The company also managed to reduce its debt by $426 million year-to-date. In addition, the semiconductor revenue rose by 3% to $378 million.
MKS Instruments also adopted new bylaws and initiated the declassification of its board. The company anticipates this process will culminate by the 2028 annual meeting of stockholders. This move aligns with the universal proxy rules adopted by the Securities and Exchange Commission, aiming for a more transparent and fair process for stockholder voting.
Analysts from JPMorgan (NYSE:JPM) and Goldman Sachs (NYSE:GS) have recently updated their stance on MKS Instruments. JPMorgan initiated coverage on MKS Instruments with an Overweight rating and a price target of $145.00, highlighting the company's role in providing critical subsystems for industry leaders.
On the other hand, Goldman Sachs maintained a Neutral rating on MKS Instruments and raised the stock target, reflecting a more optimistic outlook for the company, particularly in its Semiconductor and Electronics & Packaging (NYSE:PKG) segments.
Lastly, MKS Instruments announced the construction of a new semiconductor factory in Malaysia, aiming to diversify manufacturing risk. The company also reported increased bookings for PCB equipment tied to smartphone and AI applications. Looking ahead, MKS Instruments projected Q4 revenue to be between $910 million and $950 million, with semiconductor revenue expected at $380 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.